Study digs deep on clinical trials to find out what sponsors want
The survey included 127 pharmaceutical sponsor respondents and 79 research site respondents, analyzing their perspectives working together on site feasibility
READ MOREOctober 5, 2026
The survey included 127 pharmaceutical sponsor respondents and 79 research site respondents, analyzing their perspectives working together on site feasibility
READ MOREThe association says the day (May 20) is a ‘joyful opportunity to pause in reflection, recognition, and admiration of all
READ MOREThis round was led by new investor Questa Capital, with participation from existing investors Vive Collective and South Park Commons.
READ MOREOne2Treat aims to make the clinical trial process as seamless as possible and answered a number of the questions we
READ MORESamuel Poulin, presented Install-VASc and shared his insights into another innovative project aimed at transforming ultrasound-guided catheter insertion, highlighting the
READ MOREAccording to the report, the race to create antibiotics and antifungals to conquer superbugs is falling perilously short, which the
READ MOREOne2Treat aims to make the clinical trial process as seamless as possible and answered a number of the questions we
READ MOREHere she explains all about the challenges and triumphs that saw her reach her position of chief medical officer at
READ MOREDurect Corporation is a late-stage biopharma company championing the development of epigenetic therapies to transform the treatment of serious and
READ MOREThe goal is to propel clinical trials aimed at speeding-up the diagnosis and treatment of ME/CFS and long COVID patients. The
READ MOREThis significant 510(k) clearance permits the use of HALO AP Dx in conjunction with the Hamamatsu NanoZoomerS360MD Slide scanner for
READ MOREShe has a PharmD-PhD in Medical Physics and is a seasoned professional with a deep understanding of healthcare, law, and
READ MOREBPR: What new products or innovations is Novartis showcasing at BIO 2024 this year? At BIO 2024, Novartis Contract Manufacturing
READ MOREBPR: What new products or innovations is your company showcasing at BIO 24? This year, we’re showcasing our fully integrated,
READ MOREBPR: What new products or innovations is Cytiva showcasing at BIO 2024 this year? BIO is a very important convention
READ MOREBPR: What new products or innovations is your company showcasing at BIO 2024 this year? This year we are delighted to
READ MOREWhile antimicrobial resistance is on the rise, a greater number of people still succumb to infections caused by drug-sensitive bacteria.
READ MOREDetailed results from studies Oasis 1 and 2 will be showcased at the 2024 ACOG Annual Clinical & Scientific Meeting
READ MOREThe drug, SRP-001’s promising results from its phase 1 trial were also published. The announcement was made by South Rampart
READ MOREBPR: What new products or innovations is Abzena showcasing at BIO 2024 this year? Abzena has recently launched our AbZelect and
READ MOREPresented at ISPOR 2024, the findings emphasize the need for integrating patient needs and preferences into strategies for managing unhealthy
READ MOREThe company says its new product, built on its advanced Lycagel pea starch technology, offers manufacturers the freedom to select
READ MOREThis official launch marks a significant advancement in patient care in mainland China, introducing a new era in the treatment
READ MOREThis move is part of a larger €3.5 billion program within the country. The investment will be allocated to facilities
READ MOREBrian Hashemi, executive chairman and CEO of Novigenix, and Sabine Tejpar, founder of the IMMUcan Consortium, are leading this collaborative
READ MOREThe Virginia-based company has revealed promising results from its phase 1b clinical trial assessing RDX-002, a novel small molecule therapy
READ MOREThe money is to support the development of breath-based diagnostics for infectious diseases. The funding comprises a $5 million equity
READ MOREYesterday, (April 29), during a packed program of events, OSP was invited to watch presentations from four startups nurtured by
READ MOREThis offering aims to streamline the identification of synthetic routes for novel active pharmaceutical ingredients (APIs) by using Lonza’s extensive
READ MORETitled ‘State of the Discovery Nation (SODN) 2024: Fostering a Dynamic, Sustainable Medicines Discovery Sector,’ the report published in conjunction
READ MOREThe agreement, announced today, underscores Shionogi’s dedication to expanding its pipeline in the rare disease domain. According to the National
READ MOREThis first-in-human study aims to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of NBI-1117567 in healthy adult participants. The compound,
READ MOREAs Mental Health Awareness Week 2024 approaches, employers must recognize the power of data in improving staff wellbeing. Peter Taylor,
READ MOREThis week the second in the series comes from Jonathan Boudreau, a co-founder of Displaid and a finalist in the
READ MOREThis initiative will integrate select Walgreens community pharmacies as clinical trial sites, focusing on phase 3 trials for individuals grappling
READ MOREHaving been originally interested in engineering, she soon realized that path was not the best for the set of skills
READ MOREThe ongoing construction and validation activities mark a significant step in the company’s ambitious $100 million capital investment project, tipped
READ MOREInizio Engage, a life science consulting firm, is aiming to address this challenge through its data-driven and evidence-based methodology. During
READ MOREUsing artificial intelligence (AI), genetic engineering, and robotics, the company said it proudly introduces the world’s first automated animal research
READ MOREStarting on May 27 in London, this practitioner program is designed for healthcare professionals and students in professional training who
READ MOREHowever, Canadian company Organon wants to change this, a spin off from Merck & Co., Inc., it has a mission to focus
READ MOREHowever, Canadian company Organon wants to change this, a spin off from Merck & Co., Inc., it has a mission to focus
READ MORELGM Pharma, under Raje’s visionary stewardship, has undergone a remarkable journey of expansion and transformation since its acquisition by New
READ MOREBPR: Could you give us an overview of your work? I joined Calliditas Therapeutics as CEO in 2017, and in
READ MOREYesterday, (April 29), during a packed program of events, OSP was invited to watch presentations from four startups nurtured by
READ MOREThis offering aims to streamline the identification of synthetic routes for novel active pharmaceutical ingredients (APIs) by using Lonza’s extensive
READ MOREThe money is to support the development of breath-based diagnostics for infectious diseases. The funding comprises a $5 million equity
READ MOREWendy specializes in applying advanced methodologies to address complex healthcare research challenges and has used machine learning and other predictive
READ MOREThe Virginia-based company has revealed promising results from its phase 1b clinical trial assessing RDX-002, a novel small molecule therapy
READ MOREOSP caught up with them before the event, which is taking place in the Pennsylvania Convention Center, Philadelphia, between May
READ MORE“The extended approval allows enzalutamide to be administered either as monotherapy or in combination with androgen deprivation therapy (ADT) for
READ MOREShe works as joint chief operating officer at a specialist biometrics CRO called Quanticate where she looks after the programming and
READ MOREWe caught up with the company once more and put a few more questions to CEO Sebastian Coppe about the
READ MOREInizio Engage, a life science consulting firm, is aiming to address this challenge through its data-driven and evidence-based methodology. Duering
READ MORELGM Pharma, under Rajeev’s visionary stewardship, has undergone a remarkable journey of expansion and transformation since its acquisition by New
READ MOREIt has been widely reported that in early February US intelligence officials told senators working on a biotech security bill,
READ MOREThe company says its renowned ImmunoINSIGHTS platform is recognized for its prowess in antibody marker discovery and will now be
READ MOREThe collaboration marks a significant stride towards shifting symptom assessment paradigms in Rett syndrome through the use of cutting-edge wearable
READ MOREThis achievement marks a significant milestone in the company’s journey, granting European Union medical providers access to a life-saving device
READ MOREIt is now poised to become the first facility in the United States dedicated to producing wearable rings. This strategic move
READ MOREBPR: What new products or innovations is your company showcasing at CPHI North America this year? We are a CMO
READ MOREBPR: What new products or innovations is your company showcasing at CPhI North America this year? With the new acquisitions
READ MOREWe delved into the fascinating world of vaccine adjuvants, particularly focusing on QS-21, a purified plant extract derived from the
READ MOREAs chief delivery officer, biometrics services at eClinical Solutions, Katrina is driving clinical data transformation, and building a thriving services
READ MOREMainz Biomed has been manufacturing ColoAlert which is a non-invasive mt-stool DNA screening test designed for early detection of cancer.
READ MOREThe company said its project represents a significant investment of $200 million over the past four years, with an additional
READ MOREThe company was founded by healthcare technology startup veteran John Romano, and the company launched a pilot program in Ohio
READ MOREAs the company will be attending CPhI North America, OSP caught up with Hamilton Lenox, senior vice president of business
READ MOREFollowing on from this news, OSP put several questions to the pharma giant to dig deeper into the study. Can
READ MOREThe state-of-the-art facility will be an innovation and co-creation/working lab that supports the creation, testing, and validation of new services
READ MOREThese findings, set to be showcased at the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Global event in
READ MOREIn her current role as senior director of integrated pharmacovigilance (PV) solutions, she provides senior leadership and oversight to the
READ MOREThis strategic move, the company says, aligns with Qinecsa’s vision to emerge as the premier provider of digital pharmacovigilance solutions.
READ MOREThe project represents a significant investment of $200 million over the past four years, with an additional $300 million earmarked
READ MOREThe successful completion of the preclinical toxicity program for NBI-1117568, an oral M4 receptor agonist, marks a crucial step in
READ MOREOSP spoke to Frontsin about why the CROs are under greater pressure to deliver measurable results quickly at lower costs. He
READ MORELeniolisib, marketed as Joenja in the US, obtained FDA approval in March 2023 for treating APDS in adult and pediatric
READ MOREThe investment will accelerate the development of D3 Bio’s pipeline of oncology compounds, particularly its lead asset DS3-001. D3S-001 is
READ MOREAndreas Raabe, the visionary CEO behind Adragos Pharma, shares his insights into the company’s recent expansion and strategic objectives. With
READ MOREFounded in 2018 by a group of industry veterans with diverse expertise, the company has swiftly carved a niche for
READ MOREThe National Institute for Health and Care Excellence (NICE) has endorsed atogepant, a novel oral medication, as a preventive treatment
READ MOREThis was announced yesterday (April 12) by the executive officer, Isao Teshirogi, of Shionogi BV, the European subsidiary of Shionogi
READ MOREThis discovery marks a significant moment for Cystic Fibrosis treatment, with experts hailing it as a breakthrough. Lead researchers have
READ MOREBy Isabel Cameron and Liza Laws 11-Apr-2024 – Last updated on 11-Apr-2024 at 12:27 GMT Facebook Twitter Linkedin Email to
READ MOREPrenosis, a player in the realm of health technology, has secured this milestone with the full authorization of its diagnostic
READ MOREOSP: Could you give us an overview of your work? With more than 30 years of experience in the clinical
READ MOREThis update introduces three new AI tools geared towards providing patients with deeper insights into their health records, thereby enhancing
READ MOREThis partnership aims to eliminate hepatitis C by 2025, aligning with global efforts to eradicate the virus and improve public
READ MOREClinicians in Scotland can now administer dostarlimab in conjunction with platinum-containing chemotherapy for adult patients diagnosed with mismatch repair deficient
READ MOREThe investment will accelerate the development of D3 Bio’s pipeline of oncology compounds, particularly its lead asset DS3-001. D3S-001 is
READ MOREIt is the first and only once-daily single-tablet combination therapy by the US Food and Drug Administration (FDA). OPSYNVI combines
READ MOREThis milestone marks a significant expansion of Beacon’s analysis platform, extending its application from at-home sleep monitoring to comprehensive coverage
READ MOREQ: How has the use of data evolved in clinical trials and what are the challenges that the industry is
READ MOREThe drug is intended for the treatment of advanced endometrial cancer and the news carries significant weight as it comes
READ MOREThe collaboration, announced today (April 3), is poised to leverage advanced AI and biophysical modeling to gain deeper insights into
READ MOREDuring the successful SCOPE Summit held in Orlando earlier this year, OSP was delighted to catch up with Matt Walz,
READ MOREThe company is aiming to transform pharmaceutical shipping and storage standards worldwide. Engineered to meet the evolving needs of the
READ MOREThe news that broke yesterday (April 3) confirmed the collaboration’s aim to speed up the creation of safer and more
READ MOREThe company is aiming to transform pharmaceutical shipping and storage standards worldwide. Engineered to meet the evolving needs of the
READ MOREThe company wantd to share some of its highlights and significant advancements in both clinical and preclinical programs. The company
READ MOREWe sat down with Dr Laura to find out the origins of her fascination with science, the importance of effective
READ MOREWith this acquisition, Upsher-Smith now operates as a wholly-owned subsidiary under the Bora Group umbrella. Bobby Sheng, chairman and CEO
READ MOREThe device is aimed at transforming the diagnosis and management of diffuse liver diseases through advanced AI-driven MRI analysis. The
READ MOREOSP: Could you start by sharing a bit about your background and how you got involved with Cluepoints? PH: Certainly.
READ MOREAt the heart of this initiative lies the deployment of one of the world’s most powerful AI supercomputers, signaling a
READ MOREThis is intending to advance the development of personalised medicines, improve drug efficacy and outcomes in patients with specific chronic
READ MOREFrom math hater to a leader in clinical data, it’s been a long journey for Jennifer Visser-Rogers, vice president for
READ MOREThe trial, already underway at King’s College London, will now expand to include Clerkenwell Health’s research facility near Harley Street,
READ MOREIt was an insightful and interesting discussion about feeling close to patients as well as the importance of having a
READ MOREIn April 2022, Anju, a leading provider of comprehensive software solutions to the life sciences industry, announced the appointment of
READ MOREThis milestone marks a significant expansion of Beacon’s analysis platform, extending its application from at-home sleep monitoring to comprehensive coverage
READ MORELL: Before we delve into the specifics of your work at Atropos Health, could you provide a bit more background
READ MOREIn an interview he spoke to OSP about data integration and overcoming challenges to optimise clinical trial diversity. OSP: How
READ MORELed by Cenitz and joined by investors including KIMA Ventures, Advans Lab, and Bpifrance, the funding will support Metyos in
READ MOREBy integrating various patient-centric outcomes into a single treatment assessment, One2Treat aims to accelerate the delivery of new treatments to
READ MOREThe Foundation is a patient-led nonprofit organization dedicated to enhancing access to diagnosis, research, and care for individuals grappling with
READ MOREIt is the first and only once-daily single-tablet combination therapy by the US Food and Drug Administration (FDA). OPSYNVI combines
READ MOREDuring SCOPE 2024 in Orlando, Dawn Kaminski, vice president of business development operations at eClinical Solutions, shared valuable insights into
READ MOREThis is the company’s approach despite being amidst increasing disruptions to global trade. With 1,000 jobs already created and plans
READ MOREmyTomorrows is a global health technology company and says it is revolutionizing the landscape of clinical trial accessibility through its
READ MOREOutsourcing Pharma addressed a number of those attending to produce a ‘written roundtable of what these companies wanted to achieve
READ MOREShe has held leadership positions in project management, technical operations, and business development. Working in the CRO and CDMO environment
READ MOREThe news comes after AstraZeneca CEO Pascal Soriot previously branded the UK as a ‘very unattractive’ place to do business.
READ MOREThe device is aimed at transforming the diagnosis and management of diffuse liver diseases through advanced AI-driven MRI analysis. The
READ MOREThis significant investment marks the largest by Merck’s Life Science business sector in the Asia-Pacific region to date and underscores
READ MOREThe site, in Vacaville, California, is one of the largest biologics manufacturing facilities in the world, with a total bioreactor
READ MOREAccording to Roquette, the tie-up will ‘rebalance’ its portfolio across health and nutrition, as well as expanding its pharma product
READ MOREThis acquisition marks a significant milestone in the healthcare industry, particularly in the field of neuroscience, as it focuses on
READ MOREWith a dual focus on fostering innovation and ensuring patient safety, the FDA’s approach seeks to provide regulatory predictability, promote
READ MOREThe drug is aimed at treating chronic stable angina pectoris and conducted in Portugal, the exploratory phase 1a pharmacokinetics study,
READ MOREThis approach, along with the increasingly popular practice of cold exposure, is reshaping the pharma and wearable industry’s understanding of
READ MOREThe analysis, conducted by York Health Economic Consulting (YHEC), revealed compelling insights into the efficacy and cost-effectiveness of Celadon’s cannabis-based
READ MOREThis startup, born out of AION Labs’ startup challenge, aims to enhance the development of biological therapeutics by using the
READ MORECould you give us an overview of your work? I am the chief innovation officer at Maravai Life Sciences, the
READ MOREI recently had the privilege of engaging in an enlightening conversation with Dave Hanaman, the co-founder of Curavit. Our conversation
READ MOREeClinical Innovations Streamline Clinical Trial Processes: Insights from Dawn Kaminski In the fast-evolving landscape of clinical trials, technological advancements play
READ MOREPartnering with scale-up Wazoku, Angelini Pharma announced yesterday (March 11) that it aims to make use of the collective wisdom
READ MOREThe company has taken a significant step towards its international expansion by establishing a new facility in Boston, which is
READ MOREIt says three of its companies have recently made groundbreaking achievements including Beckley Psytech, Filament Health, and MindBio Therapeutics. With
READ MOREThe purpose of the discussion was to delve a bit deeper into the challenges and advancements in the pharmaceutical industry,
READ MOREJames Riddle, the company’s senior vice president of global review services operations, shares valuable insights into the company’s vision and
READ MOREThe announcement was made at Biomarkers UK, and it was used as an opportunity to showcase Metabolon’s latest platform designed,
READ MOREThey discuss their roles and experiences and how Medidata handles clinical research. The conversation covers topics ranging from patient engagement
READ MOREThis expansion, powered by True Software as a Service (SaaS), introduces advanced self-service configuration management capabilities, empowering users to streamline
READ MOREThese expansions cater to the rising demand for commercial manufacturing, packaging, and peptide production, bolstering the operations of its business
READ MOREDuring SCOPE 2024 held in Orlando, he shared insights into the complexities of sample management and data reconciliation, alongside precision
READ MOREThis investment is poised to propel financial inclusion and equality for those navigating the challenges of dementia. It is geared
READ MOREBPR: Could you give us an overview of the work that you do at Purolite? What do you oversee at
READ MOREThis collaboration integrates Ginkgo’s licensable assets and manufacturing capabilities with Form Bio’s cutting-edge AI-driven solutions for gene therapy optimization. The
READ MORETo find the 40, it will need to screen up to 1,000 people which is why several leading veterans’ charities
READ MOREThe partnership aims to champion innovative solutions for the early stages of the drug discovery process. The companies will focus
READ MOREThey discuss their roles and experiences and how Medidata handles clinical research. The conversation covers topics ranging from patient engagement
READ MOREThey are across diverse therapeutic areas regarding their participation in clinical trials, challenges faced, and the status of digitalization within
READ MOREShe explains how the intense experience now gives her a new sense of pride and dedication to the transformation of
READ MOREThis partnership marks Pramana’s integration into the Proscia Ready partner alliance, aimed at empowering life sciences organizations and diagnostic laboratories
READ MOREThe company has officially submitted its Duchenne Video Assessment (DVA) qualification plan to the US Food and Drug Administration (FDA)
READ MOREThis dedicated platform aims to bolster small- and medium-sized biotech organisations by providing them with essential resources and support to
READ MOREDeploying genomic technologies helps researchers to better understand the causal mechanisms of diseases improving the accuracy of diagnoses which can
READ MOREThe company focuses on discovering and developing small-molecule, targeted therapeutics for the treatment of fibrotic disease and cancer. RXC008 is
READ MOREThe company says this achievement signifies a major advancement in research and development capabilities within the pharmaceutical industry, driven by
READ MOREAs a result, the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive
READ MOREShe explains how the intense experience now gives her a new sense of pride and dedication to the transformation of
READ MOREThey are across diverse therapeutic areas regarding their participation in clinical trials, challenges faced, and the status of digitalization within
READ MOREGone are the days when oral methods were the primary means of administering medication. Today, continuous innovations have expanded the
READ MORECymaBay Therapeutics, Inc., a biopharmaceutical company focusing on innovative therapies for liver and chronic diseases, recently (Feb 21) announced the
READ MOREThis collaboration aims to streamline the process of capturing cognitive function and eCOA/ePRO data, marking a significant milestone in the
READ MOREAccording to the National Instituye of Arthritis and Musculoskeletal and Skin Diseases, psoriasis is a chronic, long-lasting disease in which the
READ MOREIt was created by The European Organization for Rare Diseases (EURORDIS) to bring together industry stakeholders to advocate for increased
READ MOREBrian Burkhardt began the Oliver Patch Project in 2020 after his son, Oliver, was diagnosed. Children going through treatment can
READ MOREAstraZeneca’s small molecule Tagrisso (osimertinib) with the addition of chemotherapy has been approved in the US for the treatment of adult patients
READ MOREGoing many steps further than just reshaping technology, Dr Karim Galil has been a big part of creating a platform
READ MOREIt is a next-generation institutional review board (IRB) recently acquired by QHP Capital, an investment manager exclusively focused on building
READ MOREHealth communications consultancy, OVID Health made the announcement today (February 22) that the only Patient Partnership Initiative (PPI) is marking
READ MOREIt can also be used as a treatment for symptoms in adult myelofibrosis patients with moderate to severe anaemia. Myelofibrosis,
READ MOREWith treatment-resistant depression, standard solutions aren’t enough. They might not make an impact or your symptoms may only improve temporarily.
READ MOREShe is now director of translational oncology, at Sygnature Discovery. OSP interviewed Jane to find out more about her career journey
READ MOREThe companies say uniting will address research site demand for end-to-end solutions to increase efficiencies across all trials. Slope is
READ MOREArvinas Inc. is using its first oral PROTAC, or PROteolysis-TArgeting Chimera, protein degrader in development to treat neurodegenerative diseases. In
READ MOREAstraZeneca’s small molecule Tagrisso (osimertinib) with the addition of chemotherapy has been approved in the US for the treatment of adult patients
READ MOREHaving spearheaded the development of companies focused on CAR-T, CAR-NK, and gene-editing technologies, Vnook encountered challenges with CAR-T efficacy on
READ MOREAccording to the National Instituye of Arthritis and Musculoskeletal and Skin Diseases, psoriasis is a chronic, long-lasting disease in which the
READ MORESome of the biggest subject areas included overburdened clinical sites along with patient retention. To improve clinical research, these key
READ MOREThe company says patients currently have to self-administer large volumes of cannabidiol (CBD) to achieve a helpful therapeutic outcome. The
READ MOREThe company, a provider of patient-centric data analytics made the announcement today (February 6), that this unparalleled volume of data
READ MOREThe trial met its primary and key secondary endpoints, making ensitrelvir the first antiviral agent to show both clinical symptom
READ MORERepare has said that it will take back control its global development and commercialization rights to camonsertib (RP-3500), it says
READ MOREOmaveloxolone will be the first therapy within the European Union to treat Friedreich’s ataxia (FA) in adults and adolescents aged
READ MOREThanks to an injection of funds from private equity firm, Traditum, funds raised are now around the £4 million mark
READ MORERelated tags appointments People on the move Pharma industry Jobs Outsourcing Pharma and BioPharma Reporter breaks down the key people
READ MOREThe digital health technology and data company made the announcement last week (February 6) that by using the platform, it
READ MOREThe announcement was made today (January 30) that there was marketing approval by the Pharmacy and Poisons Board of Honk
READ MOREThe Global Council is a small and exclusive top-tier group of AI tech, academia, regulatory agency leaders, and the life
READ MOREMedable partnered with Duke University Department of Population Health Sciences Bioethics and stakeholder (BASE) lab for the pilot study that
READ MOREUstekinumab is a human IgG1қ monoclonal antibody that binds to the p40 protein subunit used by both the interleukin-12 and
READ MOREVepdegestrant is a novel oral PROteolysis Targeting Chimera (PROTAC) ER degrader specifically for estrogen receptor-positive and HER2-negative metastatic breast cancer previously
READ MOREThanks to an injection of funds from private equity firm, Traditum, funds raised are now around the £4 million mark
READ MORERelated tags appointments People on the move Pharma industry Jobs Outsourcing Pharma and BioPharma Reporter breaks down the key people
READ MOREBrainomix 360 (formerly known as e-Stroke) helps clinical decision-making in stroke and was among more than a dozen technologies assessed
READ MOREShe loves her job and works within a team that believes in the power of diverse perspectives and robust discussions.
READ MOREShe loves her job and works within a team that believes in the power of diverse perspectives and robust discussions.
READ MORE